MLchartDataset catalogue

SGI-110

Term · Oncology and biomedicine · MLC-T-ONC-007722

A substance being studied in the treatment of some types of cancer. SGI-110 may stop the growth of tumor cells by blocking some of the enzymes needed for cells to divide. It may also make cancer cells more sensitive to other anticancer drugs. SGI-110 is a type of antimetabolite Also called guadecitabine.

Table 1. Record
IdentifierMLC-T-ONC-007722
FieldOncology and biomedicine
Expansionsguadecitabine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-007722",
  "term": "SGI-110",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of some types of cancer. SGI-110 may stop the growth of tumor cells by blocking some of the enzymes needed for cells to divide. It may also make cancer cells more sensitive to other anticancer drugs. SGI-110 is a type of antimetabolite Also called guadecitabine.",
  "expansions": [
    "guadecitabine"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/sgi-110/"
}

Record 14,914 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.